Bristol Myers Squibb (BMS) has secured another win for Opdivo (nivolumab), becoming the only FDA-approved PD-1 inhibitor for resectable non-small cell lung cancer NSCLC in both a neoadjuvant-only ...
Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has cleared ...
Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour BioMed for a multiyear research deal. The new pact will see the companies ...
Ford CEO Jim Farley has gone on the record with his support for development of a new rear-wheel drive Ford sedan. When asked on high-profile US YouTube channel Forrest’s Auto Reviews if he thinks ...
Major contract electronics makers are accelerating strategic realignments in line with the rapid development of automotive electronics and architectures for software-defined vehicles (SDV). Foxconn ...
Pilots of a Beechcraft King Air B200 consciously elected to allow Garmin's Autoland system to complete their flight after experiencing rapid cabin depressurisation, according to the charter operator ...
You can watch live video of the university’s resident peregrine falcons - our honorary River Hawks - as they mate, hatch and raise their chicks on top of Fox Hall. The female falcon, Merri, was able ...
A published image of a 10X prototype in Bordeaux appears to show ground tests underway According to sources, the Dassault Falcon 10X is expected to begin flight testing in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback